Company intelligence / Profile preview
COBIK
Ajdovščina, Sloveniacobik.si ↗
- Ownership
- Private
- Employees
- ~28
- Development stage
- Preclinical
01
Overview
COBIK develops vaccines, gene therapies, and antibacterial products using advanced modalities such as nucleic acids, viral vectors, protein nanoparticles, and virus-like particles. The company has founded several spinouts to advance programs into pre-clinical and clinical trials. It is recognized for its innovation in bioprocessing workflows and collaborative projects with academic and industry partners. Specific clinical results are not publicly detailed but the company is active in proof-of-concept through early clinical stages.
- Therapeutic areas
- Rare DiseasesInfectious Diseases
- Modalities
- Nucleic acid therapyViral vector therapyProtein nanoparticle therapyVirus-like particle therapySmall molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Academic institutions via Biopharm.si & Smartgene.si projects
Beyond the preview
Go deeper on COBIK.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on COBIK.